Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
International Clinical Psychopharmacology|August 18, 2022
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational studyKotaro Hatta, Chie Usui, Hiroyuki Nakamura
Psychiatry and Clinical Neurosciences|December 21, 2012
Urine catecholamine levels are not influenced by electroconvulsive therapy in depression or schizophrenia over the long termMasanobu Ito, Kotaro Hatta, Chie Usui, et al.
Psychiatry and Clinical Neurosciences|December 15, 2010
Utility and sufficiency of psychiatric inpatient units in general hospitals: a cross-sectional study in TokyoKotaro Hatta, Hiroyuki Nakamura, Chie Usui, et al.
Nippon Ganka Gakkai Zasshi|June 6, 2003
[Pathophysiology and diagnosis of congenital periodic alternating nystagmus]Takao Hayashi, Fumiyo Hasegawa, Chie Usui, et al.
Psychiatry and Clinical Neurosciences|April 27, 2010
Open wards versus locked wards of general hospitals in the treatment of psychiatric patients with medical comorbidities: a cross-sectional study in TokyoKotaro Hatta, Chie Usui, Hiroyuki Nakamura, et al.
The Journal of ECT|April 17, 2007
Pulmonary edema after electroconvulsive therapy in a patient treated for long-standing asthma with a beta2 stimulantKotaro Hatta, Akiyoshi Kitajima, Masanobu Ito, et al.
Plos One|November 14, 2009
Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpointNagafumi Doi, Yoko Hoshi, Masanari Itokawa, et al.
Modern Rheumatology|December 4, 2012
An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgiaHiroyoshi Ohta, Hiroshi Oka, Chie Usui, et al.
The Journal of ECT|December 20, 2007
Maximal response to electroconvulsive therapy for the treatment of catatonic symptomsKotaro Hatta, Koichi Miyakawa, Tsuneyoshi Ota, et al.
Arthritis Research & Therapy|October 16, 2012
A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgiaHiroyoshi Ohta, Hiroshi Oka, Chie Usui, et al.
Pageof 7